Orthofix Medical (OFIX) Net Equity Issued and Repurchased (2010 - 2025)

Orthofix Medical's Net Equity Issued and Repurchased history runs 16 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• Quarterly Net Equity Issued and Repurchased fell 3.63% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (up 1.94% YoY) and the FY2025 annual result came in at $5.9 million, down 5.24% from the prior year.
• Net Equity Issued and Repurchased was $2.8 million for Q4 2025 at Orthofix Medical, up from $36000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $3.0 million in Q2 2025 and bottomed at $36000.0 in Q3 2025.
• A 5-year average of $1.9 million and a median of $2.3 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased jumped 81.12% — and 2025, when it plunged 70.0%.
• Orthofix Medical's Net Equity Issued and Repurchased stood at $2.6 million in 2021, then fell by 25.1% to $1.9 million in 2022, then jumped by 41.97% to $2.8 million in 2023, then gained by 7.13% to $2.9 million in 2024, then dropped by 3.63% to $2.8 million in 2025.
• Business Quant data shows OFIX's Net Equity Issued and Repurchased at $2.8 million in Q4 2025, $36000.0 in Q3 2025, and $3.0 million in Q2 2025.